These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28600804)

  • 1. Noninvasive pulmonary transit time: A new parameter for general cardiac performance.
    de Lepper AGW; Herold IHF; Saporito S; Bouwman RA; Mischi M; Korsten HHM; Reesink KD; Houthuizen P
    Echocardiography; 2017 Aug; 34(8):1138-1145. PubMed ID: 28600804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary transit time measurement by contrast-enhanced ultrasound in left ventricular dyssynchrony.
    Herold IH; Saporito S; Mischi M; van Assen HC; Bouwman RA; de Lepper AG; van den Bosch HC; Korsten HH; Houthuizen P
    Echo Res Pract; 2016 Jun; 3(2):35-43. PubMed ID: 27249553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Dalos D; Mascherbauer J; Zotter-Tufaro C; Duca F; Kammerlander AA; Aschauer S; Bonderman D
    J Am Coll Cardiol; 2016 Jul; 68(2):189-99. PubMed ID: 27386773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular global longitudinal strain provides prognostic value incremental to left ventricular ejection fraction in patients with heart failure.
    Motoki H; Borowski AG; Shrestha K; Hu B; Kusunose K; Troughton RW; Tang WH; Klein AL
    J Am Soc Echocardiogr; 2014 Jul; 27(7):726-32. PubMed ID: 24679740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D and 2D left ventricular systolic function imaging-- from ejection fraction to deformation. Cardiac resynchronization therapy--substudy.
    Szulik M; Śliwińska A; Lenarczyk R; Szymała M; Kalinowski ME; Markowicz-Pawlus E; Kalarus Z; Kukulski T
    Acta Cardiol; 2015 Feb; 70(1):21-30. PubMed ID: 26137800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy.
    Cikes M; Sanchez-Martinez S; Claggett B; Duchateau N; Piella G; Butakoff C; Pouleur AC; Knappe D; Biering-Sørensen T; Kutyifa V; Moss A; Stein K; Solomon SD; Bijnens B
    Eur J Heart Fail; 2019 Jan; 21(1):74-85. PubMed ID: 30328654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability, repeatability, and reproducibility of pulmonary transit time assessment by contrast enhanced echocardiography.
    Herold IH; Saporito S; Bouwman RA; Houthuizen P; van Assen HC; Mischi M; Korsten HH
    Cardiovasc Ultrasound; 2016 Jan; 14():1. PubMed ID: 26729228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced left ventricular mechanical dispersion at 6 months follow-up after cardiac resynchronization therapy is associated with superior long-term outcome.
    van der Bijl P; Khidir MJH; Leung M; Yilmaz D; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Heart Rhythm; 2018 Nov; 15(11):1683-1689. PubMed ID: 29753023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the CRT-SCORE for Shared Decision Making in Cardiac Resynchronization Therapy in Patients With a Left Ventricular Ejection Fraction of ≤35.
    Höke U; Mertens B; Khidir MJH; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 Dec; 120(11):2008-2016. PubMed ID: 29031415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure.
    Kjaer A; Hildebrandt P; Appel J; Petersen CL
    Int J Cardiol; 2005 Mar; 99(2):301-6. PubMed ID: 15749191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation.
    Serdoz LV; Daleffe E; Merlo M; Zecchin M; Barbati G; Pecora D; Pinamonti B; Fantoni C; Lupo P; Di Lenarda A; Sinagra G; Cappato R
    Am J Cardiol; 2011 Jul; 108(1):75-80. PubMed ID: 21529746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
    Mitro P; Murin P; Valocik G; Simurda M
    Cardiol J; 2014; 21(5):524-31. PubMed ID: 24526506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Magnetic Resonance Evaluation of Pulmonary Transit Time and Blood Volume in Adult Congenital Heart disease.
    Ait Ali L; Aquaro GD; Peritore G; Ricci F; De Marchi D; Emdin M; Passino C; Festa P
    J Magn Reson Imaging; 2019 Sep; 50(3):779-786. PubMed ID: 30838716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between paced QRS duration and left cardiac structures and function.
    Su Y; Pan W; Gong X; Cui J; Shu X; Ge J
    Acta Cardiol; 2009 Apr; 64(2):231-8. PubMed ID: 19476117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.